Title | Type | SJR | H index | Total Docs. (2007) | Total Docs. (3years) | Total Refs. (2007) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2007) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 1.335 Q1 | 50 | 14 | 27 | 4907 | 98 | 27 | 1.10 | 350.50 | |
2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 4.568 Q1 | 70 | 7 | 32 | 1963 | 222 | 32 | 5.78 | 280.43 | |
3 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.083 Q1 | 99 | 17 | 54 | 3595 | 195 | 50 | 2.86 | 211.47 | |
4 | Critical Reviews in Toxicology | journal | 1.915 Q1 | 129 | 32 | 78 | 5087 | 466 | 72 | 5.55 | 158.97 | |
5 | Progress in Medicinal Chemistry | journal | 0.981 Q2 | 38 | 5 | 23 | 777 | 54 | 20 | 2.88 | 155.40 | |
6 | Natural Product Reports | journal | 2.741 Q1 | 211 | 75 | 138 | 11288 | 931 | 133 | 6.61 | 150.51 | |
7 | Advanced Drug Delivery Reviews | journal | 3.073 Q1 | 366 | 117 | 371 | 12760 | 3256 | 304 | 7.93 | 109.06 | |
8 | Current Drug Metabolism | journal | 1.367 Q1 | 122 | 76 | 150 | 8173 | 850 | 144 | 4.97 | 107.54 | |
9 | Expert Opinion on Emerging Drugs | journal | 0.950 Q2 | 54 | 45 | 124 | 4719 | 377 | 124 | 3.05 | 104.87 | |
10 | Current Pharmacogenomics | journal | 0.218 Q3 | 12 | 27 | 89 | 2689 | 55 | 89 | 0.67 | 99.59 | |
11 | Expert Opinion on Therapeutic Targets | journal | 1.433 Q1 | 106 | 134 | 227 | 13332 | 756 | 212 | 3.39 | 99.49 | |
12 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.743 Q2 | 100 | 67 | 120 | 6384 | 333 | 118 | 2.78 | 95.28 | |
13 | Cellular and Molecular Life Sciences | journal | 3.265 Q1 | 261 | 275 | 804 | 25263 | 4711 | 800 | 5.76 | 91.87 | |
14 | Current Pharmaceutical Biotechnology | journal | 0.951 Q1 | 97 | 48 | 166 | 4332 | 511 | 144 | 2.47 | 90.25 | |
15 | Advances in Antiviral Drug Design | book series | 12 | 7 | 0 | 624 | 0 | 0 | 0.00 | 89.14 | ||
16 | Inflammation and Allergy - Drug Targets | journal | 1.235 Q1 | 55 | 30 | 32 | 2674 | 92 | 28 | 2.88 | 89.13 | |
17 | Handbook of Experimental Pharmacology | journal | 1.431 Q1 | 110 | 87 | 334 | 7670 | 665 | 325 | 2.00 | 88.16 | |
18 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.160 Q4 | 30 | 27 | 27 | 2300 | 11 | 27 | 0.41 | 85.19 | |
19 | Expert Opinion on Biological Therapy | journal | 1.092 Q1 | 102 | 165 | 428 | 13835 | 1378 | 425 | 3.12 | 83.85 | |
20 | Expert Opinion on Drug Delivery | journal | 1.077 Q1 | 133 | 55 | 162 | 4415 | 519 | 155 | 2.99 | 80.27 | |
21 | Expert Opinion on Drug Discovery | journal | 0.289 Q3 | 84 | 132 | 65 | 10317 | 63 | 65 | 0.97 | 78.16 | |
22 | Progress in Drug Research | book series | 0.481 Q1 | 46 | 13 | 23 | 993 | 33 | 21 | 1.43 | 76.38 | |
23 | Expert Opinion on Pharmacotherapy | journal | 0.577 Q2 | 93 | 274 | 698 | 20007 | 1543 | 685 | 2.23 | 73.02 | |
24 | Expert Review of Vaccines | journal | 0.801 Q2 | 105 | 97 | 263 | 6944 | 575 | 241 | 2.25 | 71.59 | |
25 | Expert Opinion on Investigational Drugs | journal | 1.190 Q1 | 117 | 170 | 411 | 12057 | 1514 | 390 | 3.87 | 70.92 | |
26 | Side Effects of Drugs Annual | book series | 0.100 Q4 | 9 | 51 | 101 | 3531 | 1 | 52 | 0.02 | 69.24 | |
27 | BioDrugs | journal | 0.787 Q2 | 79 | 46 | 112 | 3178 | 323 | 110 | 2.87 | 69.09 | |
28 | Neurotherapeutics | journal | 2.567 Q1 | 136 | 80 | 162 | 5502 | 1103 | 146 | 6.15 | 68.78 | |
29 | Toxin Reviews | journal | 0.239 Q3 | 54 | 16 | 76 | 1078 | 60 | 71 | 0.64 | 67.38 | |
30 | Drugs of Today | journal | 0.541 Q3 | 57 | 72 | 247 | 4811 | 521 | 244 | 2.18 | 66.82 | |
31 | Chinese Medicine | journal | 0.145 Q4 | 56 | 13 | 4 | 867 | 2 | 3 | 0.50 | 66.69 | |
32 | Clinical Pharmacokinetics | journal | 1.429 Q1 | 184 | 68 | 241 | 4519 | 1307 | 232 | 4.92 | 66.46 | |
33 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 0.847 Q2 | 99 | 78 | 324 | 4878 | 891 | 315 | 2.35 | 62.54 | |
34 | Current Opinion in Molecular Therapeutics | journal | 0.985 Q1 | 67 | 72 | 238 | 4448 | 607 | 213 | 2.54 | 61.78 | |
35 | Current Opinion in Investigational Drugs | journal | 1.033 Q1 | 83 | 113 | 438 | 6943 | 1272 | 406 | 3.04 | 61.44 | |
36 | Neuropsychopharmacology | journal | 3.143 Q1 | 249 | 247 | 773 | 15129 | 5007 | 741 | 6.00 | 61.25 | |
37 | Pharmacogenomics Journal | journal | 1.305 Q1 | 95 | 43 | 157 | 2569 | 749 | 146 | 5.40 | 59.74 | |
38 | Psychopharmacology | journal | 2.029 Q1 | 214 | 360 | 1197 | 20492 | 5355 | 1151 | 4.20 | 56.92 | |
39 | Trends in Pharmacological Sciences | journal | 4.509 Q1 | 244 | 91 | 327 | 5036 | 3137 | 302 | 9.20 | 55.34 | |
40 | Apoptosis : an international journal on programmed cell death | journal | 1.666 Q1 | 128 | 183 | 408 | 10010 | 1529 | 404 | 3.43 | 54.70 | |
41 | Methods and Findings in Experimental and Clinical Pharmacology | journal | 0.336 Q3 | 56 | 75 | 215 | 4091 | 249 | 214 | 1.05 | 54.55 | |
42 | Ecotoxicology | journal | 0.899 Q2 | 107 | 59 | 200 | 3215 | 399 | 195 | 2.00 | 54.49 | |
43 | Expert Opinion on Therapeutic Patents | journal | 0.714 Q2 | 88 | 113 | 354 | 6110 | 508 | 343 | 1.43 | 54.07 | |
44 | Drugs of the Future | journal | 0.278 Q3 | 46 | 120 | 1347 | 6411 | 259 | 356 | 0.23 | 53.43 | |
45 | Nanotoxicology | journal | 107 | 26 | 0 | 1367 | 0 | 0 | 0.00 | 52.58 | ||
46 | ChemMedChem | journal | 0.638 Q1 | 119 | 174 | 412 | 9148 | 825 | 410 | 2.15 | 52.57 | |
47 | Molecular Diagnosis and Therapy | journal | 0.396 Q3 | 68 | 42 | 172 | 2187 | 412 | 169 | 2.21 | 52.07 | |
48 | Current Opinion in Drug Discovery and Development | journal | 1.460 Q1 | 85 | 74 | 218 | 3851 | 892 | 202 | 3.85 | 52.04 | |
49 | Particle and Fibre Toxicology | journal | 1.812 Q1 | 119 | 11 | 30 | 555 | 231 | 29 | 8.11 | 50.45 | |
50 | Drug Discovery Today | journal | 1.362 Q1 | 215 | 148 | 861 | 7463 | 2772 | 715 | 4.35 | 50.43 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®